Desk› Healthcare› Thyrocare Technologies Ltd
Thyrocare Technologies Ltd
Filing rhythm · 60 trading days
39 filings · 5 material · busiest 2026-07-23
What it files
Filings
39 in the window
-
19 August 2026
SASTDisclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
19 August 2026
Other UpdateDisclosure under Regulation 30A of LODR
Please find enclosed the Intimation regarding complete discharge and release of Transaction Documents pursuant to full redemption and repayment of Non-Convertible Debentures by API Holdings Limited
Others View filing →
-
18 August 2026
SASTDisclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Docon Technologies Pvt Ltd & PAC
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
18 August 2026
SASTDisclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 13, 2026 for Docon Technologies Pvt Ltd
Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →
-
18 August 2026
SASTDisclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for HSBC Mutual Fund
Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 View filing →
-
18 August 2026
SASTDisclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Docon Technologies Pvt Ltd
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
18 August 2026
SASTDisclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Docon Technologies Pvt Ltd & PACs
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
17 August 2026
GeneralCommunication Received From Promoter Regarding Release Of Pledge On Equity Shares Of Thyrocare Technologies Limited
Please refer the enclosed intimation letter
Company Update / General View filing →
-
17 August 2026
SASTDisclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 17, 2026 for Docon Technologies Pvt Ltd
Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →
-
14 August 2026
SASTDisclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
14 August 2026
SASTDisclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for ICICI Prudential Mutual Fund
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
13 August 2026
GeneralCommunication Received From Promoter Regarding Release Of Pledge On 1,75,00,000 Equity Shares Of Thyrocare Technologies Limited
Please find the attached disclosure received from Docon Technologies Private Limited ("Promoter") for release of pledge on equity shares of the Company
Company Update / General View filing →
-
13 August 2026
GeneralCommunication Received From Promoter Regarding Sale Of 1,57,69,696 Equity Shares Of The Company By Promoter - Docon Technologies Private Limited.
Please refer the enclosed intimation letter.
Company Update / General View filing →
-
13 August 2026
SASTDisclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Docon Technologies Pvt Ltd & PACs
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
13 August 2026
SASTDisclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Docon Technologies Pvt Ltd
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
27 July 2026
Concall TranscriptEarnings Call Transcript
Please find attached the Earnings Call Transcript held on July 23, 2026
Company Update / Earnings Call Transcript View filing →
-
24 July 2026
Newspaper PublicationNewspaper Publication
Please find attached herewith Newspaper Publication of Unaudited Financial Results for the quarter ended on June 30, 2026
Company Update / Newspaper Publication View filing →
-
24 July 2026
GeneralSubmission Of Machine-Readable Document Of Earlier Submitted Results Of The Company For The Quarter Ended On June 30, 2026
Thyrocare Technologies Limited has informed the exchange regarding submission of machine-readable document of earlier submitted results of the Company for the quarter ended on June 30, 2026
Company Update / General View filing →
-
23 July 2026
Board OutcomeBoard Meeting Outcome for Outcome Of The Board Meeting Held On July 23, 2026
Please find enclosed outcome of the Board Meeting held on July 23, 2026, inter alia, approving the unaudited financial results for the quarter ended June 30, 2026, as detailed in the enclosed letter.
Board Meeting / Outcome of Board Meeting View filing →
-
23 July 2026
ResultsUnaudited Financial Results For The Quarter Ended June 30, 2026
Please find enclosed the unaudited standalone and consolidated financial results of the Company for the quarter ended on June 30, 2026
Result / Financial Results View filing →
-
23 July 2026
Press ReleasePress Release / Media Release
Please find attached the Press Release on the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended on June 30, 2026
Company Update / Press Release / Media Release View filing →
-
23 July 2026
Investor PresentationInvestor Presentation
Please find attached the Investor Presentation on the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended on June 30, 2026
Company Update / Investor Presentation View filing →
-
23 July 2026
GeneralRe-Appointment Of Internal Auditor Of The Company
Please find attached the Intimation regarding the re-appointment of the Internal Auditor of the Company.
Company Update / General View filing →
-
23 July 2026
GeneralAnnouncement Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Please refer the enclosed intimation regarding the in-principle approval of the Board of Directors of the Company for evaluation of the proposed restructuring of the radiology business ....
Company Update / General View filing →
-
23 July 2026
GeneralAudio Recording Of Earnings Conference Call For The Quarter Ended June 30, 2026
Audio Recording of Earnings Conference Call for the quarter ended on June 30, 2026
Company Update / General View filing →
-
16 July 2026
Board MeetingBoard Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30, 2026
Thyrocare Technologies Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2026 ,inter alia, to consider and approve Unaudited Standalone ....
Board Meeting / Board Meeting View filing →
-
16 July 2026
Analyst / Investor MeetAnalyst / Investor Meet - Intimation
Thyrocare Technologies Limited cordially invites you to its "Earning Call" to be held on Thursday, July 23, 2026 at 06.00 P.M. to discuss the financial performance of the company for Q1 FY27.
Company Update / Analyst / Investor Meet View filing →
-
7 July 2026
Compliance CertificateCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find attached herewith Certificate pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2026
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
30 June 2026
AGM / EGMShareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of the 26th Annual General Meeting held on 30th June, 2026. Further the scrutinizer's report along with voting results is enclosed.
AGM/EGM / AGM View filing →
-
30 June 2026
GeneralChange In Statutory Auditors Of The Company
Please find enclosed intimation regarding change in Statutory Auditors of the Company
Company Update / General View filing →
-
30 June 2026
Charter AmendmentAmendments to Memorandum & Articles of Association
Please find enclosed intimation regarding Amendments to Memorandum of Association of the Company.
Company Update / Amendments to Memorandum & Articles of Association View filing →
-
24 June 2026
Trading WindowClosure of Trading Window
Please find attached the Intimation for Closure of Trading Window
Insider Trading / SAST / Closure of Trading Window View filing →
-
10 June 2026
GeneralCommunication To Shareholders - Intimation On Tax Deduction On Dividend
Please find enclosed communication sent to shareholders for deduction of tax on dividend.
Company Update / General View filing →
-
5 June 2026
Newspaper PublicationNewspaper Publication
Please find attached herewith copies of Newspaper Publications published on June 05, 2026, in Business Standard (English) and Navshakti (Marathi)
Company Update / Newspaper Publication View filing →
-
4 June 2026
AGM / EGMNotice Of 26Th Annual General Meeting Of Thyrocare Technologies Limited To Be Held On Tuesday, June 30, 2026 At 11:00 A.M. (IST)
Please find attached the Notice of 26th Annual General Meeting along with Annual Report for the FY 2025-26.
AGM/EGM / AGM View filing →
-
4 June 2026
Annual ReportReg. 34 (1) Annual Report.
Please find attached the Annual Report of Thyrocare Technologies Limited for the FY 2025-26.
Others / Reg. 34 (1) Annual Report View filing →
-
4 June 2026
BRSRBusiness Responsibility and Sustainability Reporting (BRSR)
Please find attached the Business Responsibility and Sustainability Reporting (BRSR) of the Company for the FY 2025-26
Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →
-
4 June 2026
Record DateRecord Date For The Purpose Of Final Dividend For The FY 2025-26 Is Tuesday, June 23, 2026
Please find attached intimation of Record Date for the purpose of final dividend for the FY 2025-26.
Corp. Action / Record Date View filing →
-
4 June 2026
GeneralLetter Sent To Members Of The Company Providing Web Link For AGM Notice And Annual Report For The FY 2025-26
Please find attached letter sent to members of the Company providing web link for the AGM Notice and Annual report for the FY 2025-26
Company Update / General View filing →